Project Grant HT9425261E065
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Trustees of Columbia University in the City of New York's Health Sciences Division a $1.645 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2028. The award supports research on treating HER2 therapy-resistant brain metastasis using antidepressants, conducted at Columbia's Health Sciences Division facility in New York, NY. This project...
- Federal Project Grant Award Summary Columbia University's Health Sciences Division received a $1.6M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2028. The award supports research investigating the role of Streptococcus in esophageal neoplasia, with research activities conducted at the institution's facilities in New York, NY. This three-year funded initiative falls within...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Trustees of Columbia University in the City of New York a $1,099,932 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective June 1, 2026, through May 31, 2030. The award supports research focused on optimization of targeted drug delivery and radiosensitizing strategies for pediatric diffuse midline glioma, a critical area aligned with the DHA's mission to transform...
- Federal Grant Award Summary The Trustees of Columbia University in the City of New York, Health Sciences Division, received a $822,499 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 15, 2025, with completion targeted for August 14, 2028. The award supports research investigating the role of methionine oxidation in cancer-associated cachexia, a condition characterized by progressive muscle and...
- Federal Project Grant Award Summary The Trustees of Columbia University in the City of New York, Health Sciences Division, received a $1.645 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective May 1, 2025, through April 30, 2028. The award funds research investigating bone fracture-induced joint bleeding and its role in posttraumatic osteoarthritis development. This research aligns with the DHA's mission...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Washington University a $699,751 Project Grant under the Military Medical Research and Development program (CFDA 12.420) on May 1, 2026, with a completion date of April 30, 2029. The award funds research to unveil mechanisms and develop innovative therapeutic interventions targeting ESR1-CCDC170 fusions in clinically aggressive, endocrine-resistant, and metastatic breast cancers. This research initiative represents the DHA's...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Trustees of Columbia University in the City of New York—Health Sciences Division a $218,055 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025, with a completion date of July 31, 2028. The award funds research titled "Enhancing Early Detection of Pancreatic Cancer Using GPT-Embedded EHR Models: A Novel Approach for Improved Predictive Performance and...
- Federal Project Grant Award Summary Award Overview The Defense Health Agency (DHA) awarded Dartmouth-Hitchcock Clinic a Project Grant of $5,163,060 under the Military Medical Research and Development program (CFDA 12.420) for research titled "Therapeutic Targeting of the Tumor Microenvironment in Triple-Negative Breast Cancer Patients at High Risk of Relapse and Preclinical Models of Lung Metastases." The award was issued on May 15, 2025, with a performance period extending through May...
- The Defense Health Agency awarded a $1,316,000 Project Grant to The Trustees of Columbia University in the City of New York (Health Sciences Division) on August 1, 2025 through the Military Medical Research and Development program (CFDA 12.420). The funding supports a 4-year research project titled "ADVANCING WRN AS A PROMISING THERAPEUTIC TARGET FOR MSI-H CANCERS" to conduct advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the...
- Federal Grant Award Summary The University of Southern California's Department of Contracts and Grants received a $1,092,695 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025, through July 31, 2029. The award supports the Convergent Science Virtual Cancer Center, a research initiative focused on advancing biomedical solutions for cancer treatment and care delivery. Under this four-year...
Columbia University's Health Sciences Division received a $750,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) with a performance period from July 1, 2026 through June 30, 2029. The award funds research to identify novel therapeutic targets that overcome treatment resistance in triple-negative breast cancer (TNBC), a particularly aggressive form of cancer with limited therapeutic options. This research directly supports the DHA's mission to transform healthcare for service members and the American public through innovative biomedical solutions addressing critical health challenges. Under this award, Columbia University will conduct hypothesis-driven basic and translational research activities focused on identifying new molecular pathways and biomarkers that contribute to therapeutic resistance mechanisms in TNBC. The research outputs will include scientific discoveries, biomarker identification, and potential therapeutic target validation that could inform the development of novel treatment strategies. As a major academic medical center with extensive capabilities in oncology research and clinical investigation, Columbia University's Health Sciences Division is well-positioned to deliver high-quality research and development services consistent with the DHA's competitive peer and programmatic review standards that emphasize both technical merit and military relevance.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $750.0k | 3/30/26 |